<DOC>
	<DOCNO>NCT01973894</DOCNO>
	<brief_summary>This study investigate independent variable may influence Midazolam Pharmacokinetics critically ill patient .</brief_summary>
	<brief_title>Midazolam Whole Body Physiologically Based Pharmacokinetic Model</brief_title>
	<detailed_description>This study three specific aim : 1. create Midazolam PBPK model base anthropometric physiopathological data enrol patient ; 2. estimate cerebral systemic Midazolam concentration ; 3. ass independent variable Midazolam pharmacokinetic critically ill patient .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>ICU admittance Caucasian Clinical indication least 72h continuous sedation Midazolam MAP 60 150 mmHg , even obtain amine support inform consent obtain Any endocranial lesion , spontaneous induce PaCO2 &gt; 60 mmHg &lt; 30 mmHg PaO2 &lt; 50 mmHg Pregnancy Anuria Any transplantation Severe hepatic failure ( Child C ) Life expectancy &lt; 72h Ketoconazole antiretrovirals therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>PBPK</keyword>
	<keyword>Midazolam</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Critically ill patient</keyword>
</DOC>